| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BG | Common Stock | Options Exercise | $25.1 K | +501 | +0.96% | $50.07 | 52.9 K | Oct 20, 2021 | Direct | F1 |
| transaction | BG | Common Stock | Sale | -$35.2 K | -400 | -0.76% | $88.00 | 52.5 K | Oct 20, 2021 | Direct | F1, F2 |
| transaction | BG | Common Stock | Options Exercise | $31.3 K | +626 | +1.19% | $50.07 | 53.1 K | Oct 21, 2021 | Direct | F1 |
| transaction | BG | Common Stock | Sale | -$44 K | -500 | -0.94% | $88.05 | 52.6 K | Oct 21, 2021 | Direct | F1, F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BG | Stock Option (Right to Buy) | Options Exercise | $0 | -501 | -1.7% | $0.00 | 29 K | Oct 20, 2021 | Common Stock | 501 | $50.07 | Direct | F1, F4 |
| transaction | BG | Stock Option (Right to Buy) | Options Exercise | $0 | -626 | -2.16% | $0.00 | 28.4 K | Oct 21, 2021 | Common Stock | 626 | $50.07 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | All of the transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2021. |
| F2 | Shares were sold for the purpose of the payment of tax liability incident to the exercise of stock options. |
| F3 | This transaction was executed in multiple trades at prices ranging from $88.00 to $88.14. The price reported reflects the weighted average sale price. The reporting person undertakes to provide to Bunge Limited, any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F4 | This option was granted on March 1, 2016 and became exercisable in three equal annual installments beginning on March 1, 2017. |